Results 151 to 160 of about 48,373 (242)

Hepatitis B virus reactivation risk in haploidentical versus matched donor transplantation: Impact of universal prophylaxis. [PDF]

Hematol Transfus Cell Ther
Chen TT, Yeh SP, Lin CC.
europepmc   +1 more source

Barriers to Hepatitis B Treatment: A Multicentre Cross‐Sectional Registry and Survey Study by the Canadian Hepatitis B Network

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Background & Aims Chronic hepatitis B (CHB) remains a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, yet treatment uptake is suboptimal even in high‐resource settings. This pan‐Canadian study aimed to quantify treatment gaps within the Canadian Hepatitis B Network (CanHepB) Registry, compare characteristics of ...
Hin Hin Ko, Jordyn Vienneau, Curtis L. Cooper, Pam Crotty, Stephen E. Congly, Mayur Brahmania, Alnoor Ramji, Erin Kelly, Angela M. Crawley, Karen Doucette, Vanessa Meier‐Stephenson, Mang Ma, Scott K. Fung, David K. Wong, Jordan Feld, Nabiha Faisal, Kelly Kaita, Carla Osiowy, Magdy Elkhashab, Edward Tam, Alexander Wong, Robert Bailey, Philip Wong, Giada Sebastiani, Tianyan Chen, Brian Conway, David Truong, Keith Tsoi, Carmine Nudo, Julie Zhu, Sébastien Poulin, Abdel‐Aziz Shaheen, Carla S. Coffin   +32 more
wiley   +1 more source

Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study. [PDF]

Infect Dis Poverty
Musabaev EI, Khodjaeva ME, Khikmatullaeva AS, Ibadullaeva NS, Shodieva FSK, Khudaykulova GK, Tadjieva NU, Amonov SB, Mirzaev UK.   +8 more
europepmc   +1 more source

Core protein mutations are key determinants of hepatitis B virus replication during the hepatitis B e antigen-negative stage. [PDF]

J Gen Virol
Flichman D, García MC, Granchetti HN, Campos R, Elizalde MM.   +4 more
europepmc   +1 more source

Prevalence and factors associated with hepatitis B surface antigen (HBsAg) positivity in Bugoye Sub-County, Western Uganda. [PDF]

Discov Public Health
Turigye B, Mulogo EM, Thompson P, Camille M, Goel V, Baguma E, Bhatti K, Boyce RM.   +7 more
europepmc   +1 more source

Factors Associated With Surface Antigen (HBsAg) Clearance in a Spanish Cohort of Chronic Hepatitis B Patients: Influence on the Long-Term Prognosis. [PDF]

J Med Virol
Gavilán P, Gavilán JC, Piserra-Lopez A.   +2 more
europepmc   +1 more source

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b. [PDF]

Front Cell Infect Microbiol
Ren X, Sheng X, Wong Z, Cui Y, Zhang Q, Song J, Zhu W, Gao Y, Hu J, Huang L.   +9 more
europepmc   +1 more source

Risk of Hepatitis B Reactivation Following Corticosteroids for Tuberculous Meningitis. [PDF]

Open Forum Infect Dis
Donovan J, Thu NTA, Nghia HDT, Bang ND, Trinh DHK, Ngoc LHB, Oanh PKN, Kestelyn E, Hung TT, Geskus RB, Thuong NTT, Phu NH, Thwaites GE.   +12 more
europepmc   +1 more source

Prevention of HBV Mother-To-Child Transmission (MTCT) Using Targeted HBV Birth Dose, and Treatment of High Viral Load Pregnant Women in Uganda. [PDF]

J Viral Hepat
Hall S, Ocama P, Leavelle D, Kiwanuka J, Lwanga B, Nankya-Mutyoba J, Pan CQ, Namulindwa C, Kasone V, Beyagira R, Razavi H.   +10 more
europepmc   +1 more source

Research progress on hepatitis B surface antigen decline and clearance. [PDF]

ILIVER
Guo YF, Sun MQ, Zhang YZ, Ji D.
europepmc   +1 more source